USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Exocad Gmbh

USPTO PatentsView assignee record - 16 granted patents across 8 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61C (DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE).

The verdict

According to USPTO PatentsView, Exocad ranks #17,655 of 50,000 tracked US assignees by granted-patent volume, with 16 patents across 8 technology areas.

#17,655
of 50,000 US assignees by volume
Top 7%
by Innovation Score (54.8/100)
27.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R17655 · Foreign Corporation #17,655 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 16 grants
  • MID-PACK #17,655/50,000
  • PHOTO-FINISH East Manufacturing
  • CPC-NARROW A61C · 8 areas
  • INNOV-PAR 54.8/100
  • CLAIMS-DENSE 27.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2022–2025 · 4y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: East Manufacturing Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Exocad

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Exocad Gmbh stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-NARROW, INNOV-PAR, CLAIMS-DENSE, TYPE-FRNCORP, SPAN-YRS, BOOK-RICH. Volume places it #17,655 of 50,000; Innovation Score 54.8/100 sits in the top 7% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is East Manufacturing Corporation (±0 grants).

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Portfolio overview

Exocad Gmbh has been granted 16 US utility patents between 2022 and 2025, placing Exocad Gmbh at #17,655 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 27.4 claims per patent with primary concentration in A61C (DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE). As a Foreign Corporation, Exocad Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Exocad sits between EPIC Semiconductors Inc (16 patents, rank #17,633) and Eavor Technologies Inc. (16 patents, rank #17,641) - the closest US assignees by grant volume. The composite Innovation Score of 54.8/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Historical data spans 2022 through 2025, with 16 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Exocad Gmbh's 27.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 8 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Who files at Exocad's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Exocad holds 16 patents at rank #17,637, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Exocad

By rank, the assignees closest to #17,637 in granted patent volume.

Leaders in A61C (Dentistry)

Other assignees with the most granted patents in Exocad's primary technology class.

Exocad's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 202220242025 11
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
Exocad Gmbh patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 1 6.3%
2024 4 25.0%
2025partial year 11 68.8%

Where it ranks

Overall rank by patents

#17,655

of 50,000 tracked assignees

Innovation Score

54.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.